NextPlat (NXPL) Other Non-Current Assets (2015 - 2026)
NextPlat's (NXPL) quarterly Other Non-Current Assets came in at $37000.0 in Q2 2026, down 57.47% year-over-year from $87000.0 in Q2 2025, and down 93.73% quarter-over-quarter from $590000.0 in Q1 2026.
Analysis
NextPlat (NXPL) Other Non-Current Assets (2015 - 2026) Analysis & Trends
NextPlat (NXPL) has reported Other Non-Current Assets for 8 consecutive years, with $37000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Other Non-Current Assets fell 57.47% year-over-year to $37000.0 in Q2 2026; TTM through Jun 2026 was $37000.0, a 57.47% decrease from a year earlier, with the FY2025 full-year figure at $37000.0, down 60.64% from the prior year.
- Other Non-Current Assets was $37000.0 for Q2 2026 at NextPlat, down from $590000.0 in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $6.1 million in Q1 2023 and troughed at $37000.0 in Q4 2025.
- A 5-year average of $428310.7 and a median of $61000.0 in 2023 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets soared 12241.56% in 2023 and plunged 99.0% in 2024, its largest moves.
- Over 5 years, Other Non-Current Assets stood at $49000.0 in 2022, then advanced by 24.49% to $61000.0 in 2023, then jumped by 54.1% to $94000.0 in 2024, then tumbled by 60.64% to $37000.0 in 2025, then changed by 0.0% to $37000.0 in 2026.
- The last three Other Non-Current Assets figures came in at $37000.0 (Q2 2026), $590000.0 (Q1 2026), and $37000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | 1.79 Bn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | 1.06 Bn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 11.74 Mn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | 80.67 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 358.00 Mn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 11.62 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | 14.42 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 33.39 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | 666,000.00 |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn | 37,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 37,000.00 |
| Mar 31, 2026 | 590,000.00 |
| Dec 31, 2025 | 37,000.00 |
| Sep 30, 2025 | 79,000.00 |
| Jun 30, 2025 | 87,000.00 |
| Mar 31, 2025 | 94,000.00 |
| Dec 31, 2024 | 94,000.00 |
| Sep 30, 2024 | 94,000.00 |
| Jun 30, 2024 | 66,000.00 |
| Mar 31, 2024 | 61,000.00 |
| Dec 31, 2023 | 61,000.00 |
| Sep 30, 2023 | 49,135.00 |
| Jun 30, 2023 | 49,373.00 |
| Mar 31, 2023 | 6.13 Mn |
| Dec 31, 2022 | 49,000.00 |
| Sep 30, 2022 | 42,424.00 |
| Jun 30, 2022 | 42,424.00 |
| Mar 31, 2022 | 49,650.00 |
| Dec 31, 2021 | 147,510.00 |
| Sep 30, 2021 | 38,706.00 |